RFC
TRIB

Russell Frank Company’s Trinity Biotech TRIB Stock Holding History

Russell Frank Company’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$5.28M Buy
3,020
+554
+22% +$882K 0.01% 1296
2015
Q4 		$4.44M Sell
2,466
-618
-20% -$1.09M 0.01% 1361
2015
Q3 		$5.29M Buy
3,084
+74
+2% +$179K 0.01% 1239
2015
Q2 		$8.15M Buy
3,010
+1,550
+106% +$4.03M 0.01% 1125
2015
Q1 		$4.22M Buy
1,460
+155
+12% +$430K 0.01% 1348
2014
Q4 		$3.42M Buy
1,305
+178
+16% +$460K 0.01% 1500
2014
Q3 		$3.09M Buy
1,127
+49
+5% +$159K 0.01% 1542
2014
Q2 		$3.72M Buy
1,078
+196
+22% +$697K 0.01% 1457
2014
Q1 		$3.21M Buy
882
+195
+28% +$767K 0.01% 1532
2013
Q4 		$2.54M Buy
687
+154
+29% +$555K ﹤0.01% 1588
2013
Q3 		$1.74M Buy
533
+162
+44% +$474K ﹤0.01% 1936
2013
Q2 		$938K Buy
+371
New +$923K ﹤0.01% 2094

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Russell Frank Company's TRIB Position: Q1 2016 in Review

Russell Frank Company increased its Trinity Biotech (TRIB) stake by 22% in Q1 2016, buying an estimated $882K and bringing the position to 3,020 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #1296.

Russell Frank Company first reported a position in TRIB in Q2 2013 and has held it in 12 quarters since. The position peaked at $8.15M in Q2 2015. 79 funds tracked by Wall St. Rank hold TRIB as of Q1 2016.

  • Russell Frank Company held 3,020 shares of Trinity Biotech worth $5.28M as of Q1 2016.
  • Russell Frank Company bought 554 Trinity Biotech shares in Q1 2016, an estimated $882K.
  • Trinity Biotech made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1296 holding.
  • Russell Frank Company first reported a position in Trinity Biotech in Q2 2013 and has held it in 12 quarters since.
  • Russell Frank Company's Trinity Biotech position peaked at $8.15M in Q2 2015.
  • 79 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.